BE1002063A4 - Association medicamenteuse a base d'un inhibiteur calcique. - Google Patents

Association medicamenteuse a base d'un inhibiteur calcique. Download PDF

Info

Publication number
BE1002063A4
BE1002063A4 BE8701236A BE8701236A BE1002063A4 BE 1002063 A4 BE1002063 A4 BE 1002063A4 BE 8701236 A BE8701236 A BE 8701236A BE 8701236 A BE8701236 A BE 8701236A BE 1002063 A4 BE1002063 A4 BE 1002063A4
Authority
BE
Belgium
Prior art keywords
association based
drug association
calcium inhibitor
calcium
drug
Prior art date
Application number
BE8701236A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002063A4 publication Critical patent/BE1002063A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE8701236A 1986-11-03 1987-10-30 Association medicamenteuse a base d'un inhibiteur calcique. BE1002063A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE1002063A4 true BE1002063A4 (fr) 1990-06-12

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8701236A BE1002063A4 (fr) 1986-11-03 1987-10-30 Association medicamenteuse a base d'un inhibiteur calcique.

Country Status (25)

Country Link
KR (1) KR960005145B1 (cs)
AT (1) AT397343B (cs)
AU (1) AU615883B2 (cs)
BE (1) BE1002063A4 (cs)
CA (1) CA1314222C (cs)
CH (1) CH677189A5 (cs)
DE (1) DE3736505A1 (cs)
DK (1) DK574087A (cs)
ES (1) ES2010524A6 (cs)
FI (1) FI874823L (cs)
FR (1) FR2605885B1 (cs)
GR (1) GR871680B (cs)
HK (1) HK138893A (cs)
HU (1) HU199681B (cs)
IE (1) IE60496B1 (cs)
IL (1) IL84343A (cs)
IT (1) IT1212037B (cs)
LU (1) LU87034A1 (cs)
MY (1) MY102124A (cs)
NL (1) NL8702502A (cs)
NO (1) NO874539L (cs)
NZ (1) NZ222401A (cs)
PH (1) PH23249A (cs)
PT (1) PT86062B (cs)
SE (1) SE8704272L (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
EP0180785A1 (de) * 1984-10-17 1986-05-14 Bayer Ag Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung
EP0265685A2 (de) * 1986-10-02 1988-05-04 Hoechst Aktiengesellschaft Kombination von Angiotensin- Converting-Enzyme-Hemmern mit Calciumantagonisten sowie deren Verwendung in Arzneimitteln

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
EP0180785A1 (de) * 1984-10-17 1986-05-14 Bayer Ag Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung
EP0265685A2 (de) * 1986-10-02 1988-05-04 Hoechst Aktiengesellschaft Kombination von Angiotensin- Converting-Enzyme-Hemmern mit Calciumantagonisten sowie deren Verwendung in Arzneimitteln

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LA REVUE DE MEDICINE INTERNE, vol. 7, no. 4, 1986, pages 433-440; A. SIMON: "Hypertension artérielle essentielle: stratégie d'emploi des médicaments antihypertenseurs" *

Also Published As

Publication number Publication date
SE8704272L (sv) 1988-05-04
GR871680B (en) 1988-05-02
SE8704272D0 (sv) 1987-11-02
DK574087D0 (da) 1987-11-02
FR2605885A1 (fr) 1988-05-06
CA1314222C (en) 1993-03-09
HU199681B (en) 1990-03-28
HUT47847A (en) 1989-04-28
HK138893A (en) 1993-12-24
PT86062A (en) 1987-12-01
IL84343A (en) 1993-07-08
FI874823A7 (fi) 1988-05-04
ATA286987A (de) 1993-08-15
AU615883B2 (en) 1991-10-17
CH677189A5 (cs) 1991-04-30
AT397343B (de) 1994-03-25
DK574087A (da) 1988-05-04
FR2605885B1 (fr) 1993-09-10
IE872951L (en) 1988-05-03
KR880006197A (ko) 1988-07-22
NZ222401A (en) 1991-04-26
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IT8748553A0 (it) 1987-10-30
FI874823A0 (fi) 1987-11-02
NL8702502A (nl) 1988-06-01
PH23249A (en) 1989-06-16
KR960005145B1 (ko) 1996-04-22
LU87034A1 (fr) 1988-05-03
ES2010524A6 (es) 1989-11-16
MY102124A (en) 1992-03-31
DE3736505A1 (de) 1988-05-05
IT1212037B (it) 1989-11-08
NO874539D0 (no) 1987-11-02
NO874539L (no) 1988-05-04
IL84343A0 (en) 1990-02-09
IE60496B1 (en) 1994-07-27
FI874823L (fi) 1988-05-04

Similar Documents

Publication Publication Date Title
ATE63813T1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ATE49126T1 (de) Mittel zur transdermalen applikation von arzneistoffen.
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
ATE91628T1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
DE3875867D1 (de) Kalziumzusaetze.
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
DE3781488D1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
BE1002504A3 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
BE1002063A4 (fr) Association medicamenteuse a base d'un inhibiteur calcique.
ATE67410T1 (de) Methode zur behandlung der antidiurese.
ATE42308T1 (de) Pharmakologisch aktive peptide.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
KR880004810A (ko) 소화성 궤양 치료제
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
BE899434A (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: *NOVARTIS A.G.

Effective date: 20021031